FTLP12

Across TCGA pan-cancer cohorts, FTLP12 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated FTLP12 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher FTLP12 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FTLP12 expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.

UCS, HNSC, and LGG are the cancer types where FTLP12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.795	0.200	<.001	88	view →
HNSC	DFS	Median	All	0.482	0.271	.004	69	view →
LGG	OS	Median	All	0.727	0.858	<.001	48	view →
DLBC	DFS	Quartile	II,III,IV	0.338	1.000	.006	37	view →
THYM	DFS	Median	III,IV	1.000	0.365	.001	18	view →
COAD	OS	Median	All	0.531	0.677	.003	16	view →
OV	DFS	Quartile	IV	0.455	0.206	.019	14	view →
BLCA	DFS	Quartile	All	0.219	0.382	.016	13	view →
MESO	DFS	Tertile	All	0.348	0.192	.011	13	view →
LIHC	DFS	Median	All	0.175	0.348	.019	11	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →
KIRC	DFS	Tertile	All	0.771	0.564	.005	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

FTLP12–UCS (OS)

Open the UCS breakdown →